CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • November 14th, 2016 • Stocosil Inc. • Pharmaceutical preparations • California
THIS CONVERTIBLE NOTE PURCHASE AGREEMENT (the “Agreement”) is made effective and dated for references purposes as of February _____, 2015 (the “Effective Date”), by and between Stocosil Inc., a Delaware corporation (the “Company”) and the investor whose name and signature are set forth on the signature page to this Agreement (the “Investor”).
ESCROW SERVICES AND CUSTODY AGREEMENTEscrow Services and Custody Agreement • November 14th, 2016 • Stocosil Inc. • Pharmaceutical preparations • Virginia
This Escrow Services and Custody Agreement (this “Agreement”) is effective this 8th day of November, 2016 (the “Effective Date”) by and among Stocosil, Inc., a Delaware corporation (“Issuer”), and Folio Investments, Inc. (“Folio”), a Virginia corporation. Issuer and Folio are hereby referred to collectively as the “Parties” or individually as a “Party”.
SECOND AMENDED AND RESTATED ENGAGEMENT LETTEREngagement Letter • November 14th, 2016 • Stocosil Inc. • Pharmaceutical preparations • Delaware
This second amended and restated engagement letter (the “Agreement”) confirms the terms upon which Stocosil Inc. (the “Client”) engages Boustead Securities, LLC (f/k/a Monarch Bay Securities, LLC) (“Boustead” or the “Placement Agent”). The Placement Agent is engaged to act as the exclusive placement agent to the Client in connection with a Financing (as defined below) of securities on behalf of the Client. The Placement Agent is also the “Financial Adviser,” which the Client hereby engages upon signing this Agreement. This Agreement amends, restates and supersedes in its entirety that certain Amended and Restated Engagement Letter dated September 19, 2016 between the Client and the Placement Agent (the “Original Letter”).
